Where does Icon Clinical Research Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Icon Clinical Research Limited ranks #47,577 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Icon Clinical Research Limited hold?

Icon Clinical Research Limited holds 5 US utility patents granted between 2017 and 2025, spanning 4 technology areas.

What is Icon Clinical Research Limited's Innovation Score?

Icon Clinical Research Limited has an Innovation Score of 30.7 out of 100 (35th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Icon Clinical Research Limited focus on?

Icon Clinical Research Limited's top technology area is G06F (Electric Digital Data Processing) with 4 patents, ranking #7,209 of 13,878 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Icon Clinical Research Limited's patent grant rate increasing or decreasing?

Icon Clinical Research Limited's recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Icon Clinical Research Limited's patents?

Icon Clinical Research Limited's patents average 18.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Icon Clinical Research Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Icon Clinical Research Limited

USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G06F (Electric Digital Data Processing).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Icon ranks #47,577 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 4 technology areas.

#47,577
of 49,997 US assignees by volume: 35th percentile
by Innovation Score (30.7/100): 18.0
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R47577 · Foreign Corporation #47,577 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #47,577/49,997
PHOTO-FINISH IC-MedTech
CPC-NARROW G06F · 4 areas
INNOV-THIN 30.7/100
CLAIMS-RICH 18.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: IC-MedTech Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Icon’s 30.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (20%) Velocity 6.7 pts (22%) Breadth 7.1 pts (23%) Claim depth 10.8 pts (35%)

Qualcomm Incorporated · highest

85
Icon Clinical Research · this assignee

31
3D Lighting… · lowest

7

What this shows Icon's Innovation Score is 30.7/100 (35th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Icon?

Each dot is one of Icon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Icon’s own 18.0 claims/patent is ABOVE the 11.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Icon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Icon's grants concentrate

Icon Clinical Research Limited is a focused PatentsView assignee: 4 CPC subclasses with 80% of grants classified under G06F (Electric Digital Data Processing). By volume, Icon sits between IC-MedTech Corp. and Idid Tecnologia Ltda.

Icon's three-year grant acceleration

Icon Clinical Research Limited shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ic-medtech

5
ICB Pharma Spolka…

5
ICE House America

5
ICE IP

5
ID Lab

5
ID Quantique

5
IDE Water

5
Idid Tecnologia L…

5
Icon Clinical Res… ◀

5

What this shows Icon holds 5 patents at rank #47,582, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Icon

By rank, the assignees closest to #47,582 in granted patent volume.

Leaders in G06F (Electric Digital Data Processing)

Other assignees with the most granted patents in Icon's primary technology class.

Icon's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 35th percentile higher than 35% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Icon Clinical Research Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	20.0%
2020	1	20.0%
2022	1	20.0%
2025partial year	2	40.0%

Which technologies does Icon Clinical Research Limited patent most?

G06F - Electric Digital Data Processing 4

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 4

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 2

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Icon Clinical Research Limited's patent record in context - here's where to go next.

Icon Clinical Research Limited's lead technology class is G06F (Electric Digital Data Processing), 80% of its portfolio - see every assignee active in that class. Explore G06F
Ranked #47,577 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Icon Clinical Research Limited against IC-MedTech Corp., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.